1 week Ago By ABMN Staff
JPMorgan Chase & Co. lifted its holdings in shares of CorVel Co. ( NASDAQ:CRVL – Free Report ) by 363.
4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 176,631 shares of the business services provider’s stock after buying an additional 138,518 shares during the period. JPMorgan Chase & Co.
owned approximately 0.35% of CorVel worth $19,652,000 at the end of the most recent quarter. Other hedge funds and other institutional investors have also recently made changes to their positions in the company.
Vanguard Group Inc. lifted its position in CorVel by 202.1% during the 4th quarter.
Vanguard Group Inc. now owns 3,281,649 shares of the business services provider’s stock worth $365,116,000 after acquiring an additional 2,195,466 shares during the period. Boston Trust Walden Corp raised its stake in shares of CorVel by 196.
8% during the fourth quarter. Boston Trust Walden Corp now owns 690,053 shares of the business services provider’s stock worth $76,775,000 after purchasing an additional 457,538 shares during the last quarter. Raymond James Financial Inc.
acquired a new stake in shares of CorVel during the fourth quarter worth $25,123,000. Charles Schwab Investment Management Inc. grew its position in CorVel by 203.
4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 261,644 shares of the business services provider’s stock valued at $29,111,000 after buying an additional 175,408 shares during the last quarter.
Finally, Bank of New York Mellon Corp increased its stake in CorVel by 184.2% in the 4th quarter. Bank of New York Mellon Corp now owns 183,447 shares of the business services provider’s stock valued at $20,410,000 after buying an additional 118,888 shares during the period.
Hedge funds and other institutional investors own 51.36% of the company’s stock. CorVel Trading Down 0.
6 % Shares of CRVL opened at $114.90 on Friday. The stock’s 50 day moving average is $111.
78 and its two-hundred day moving average is $114.98. CorVel Co.
has a twelve month low of $76.20 and a twelve month high of $128.61.
The firm has a market capitalization of $5.90 billion, a PE ratio of 67.59 and a beta of 0.
94. Insiders Place Their Bets In related news, Director Steven J. Hamerslag sold 10,000 shares of the business’s stock in a transaction dated Thursday, February 6th.
The shares were sold at an average price of $123.48, for a total transaction of $1,234,800.00.
Following the sale, the director now owns 314,000 shares of the company’s stock, valued at approximately $38,772,720. The trade was a 3.09 % decrease in their ownership of the stock.
The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link . Also, CFO Brandon O’brien sold 1,523 shares of the company’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $119.
56, for a total transaction of $182,089.88. Following the transaction, the chief financial officer now owns 17,142 shares in the company, valued at $2,049,497.
52. The trade was a 8.16 % decrease in their ownership of the stock.
The disclosure for this sale can be found here . In the last ninety days, insiders have sold 48,723 shares of company stock worth $5,757,140. Corporate insiders own 47.
57% of the company’s stock. Wall Street Analysts Forecast Growth Separately, StockNews.com upgraded shares of CorVel from a “hold” rating to a “buy” rating in a research note on Tuesday.
View Our Latest Stock Report on CorVel CorVel Company Profile ( Free Report ) CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Read More Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter ..
